“Right to Try” legislation may have compassion at its heart, but it does not do enough to ensure patient protection.
Women, like men, want good medicines that have been tested in clinical trials involving fair representation of both sexes.
Talking at women in cannabis science, and meeting Raphael Mechoulam
Digital technologies could transform healthcare.
A review of FDA data suggests that women are now better represented in clinical trials.
Pan Pantziarka and Gauthier Bouche
New cancer treatments may be lying right under our noses – if we are willing to take a commercial risk.
Could weight management replace medication as the first line treatment for type II diabetes?
What does analysis of the microbiome literature tell us about priorities and progress in the field?
If prospective registration is enforced for clinical trials, questionable results become easier to spot
Solutions are needed to teach the immune system to recognize biological drugs as partners, not plunderers.
Send me the latest from The Translational Scientist.
Register to access our FREE online portfolio, request the magazine in print and
manage your preferences.